SMTL ID : 6v6k.2 (3 other biounits)

EGFR(T790M/V948R) in complex with LN2057

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 6 residues within 4Å: Chain A: G.26, A.27, F.28, K.50, R.146, D.160 Ligand excluded by PLIP CL.3: 7 residues within 4Å: Chain B: G.26, A.27, F.28, K.50, R.146, D.160 Ligands: QQJ.4 Ligand excluded by PLIP

2 x QQJ: N-[3-({4-[4-(4-fluorophenyl)-2-(methylsulfanyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)-4-methoxyphenyl]propanamide(Covalent)

QQJ.2: 20 residues within 4Å: Chain A: L.23, V.31, A.48, I.49, K.50, L.82, L.93, I.94, M.95, Q.96, L.97, M.98, P.99, G.101, C.102, R.146, N.147, L.149, T.159, D.160 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.23, A:K.50, A:K.50, A:L.149 Hydrogen bonds: A:M.98, A:M.98, A:C.102, A:D.105, A:D.105 QQJ.4: 21 residues within 4Å: Chain B: L.23, S.25, V.31, A.48, K.50, L.82, L.93, I.94, M.95, Q.96, L.97, M.98, P.99, G.101, C.102, D.105, R.146, L.149, T.159, D.160 Ligands: CL.3 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:V.31, B:K.50, B:K.50, B:L.149 Hydrogen bonds: B:M.98, B:M.98, B:C.102, B:D.105

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heppner, D.E. et al., Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors. J.Med.Chem. (2020)

Release Date

2020-04-22

Peptides

Epidermal growth factor receptor: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

Epidermal growth factor receptor

Related Entries With Identical Sequence